<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font22">(.%) </span>
   <span class="font18">for </span>
   <span class="font16">were </span>
   <span class="font16">subjects </span>
   <span class="font15">placebo </span>
   <span class="font14">was </span>
   <span class="font14">active </span>
   <span class="font14">studies </span>
   <span class="font14">with </span>
   <span class="font14">{background </span>
   <span class="font14">treatment </span>
   <span class="font13">multiple-dose </span>
   <span class="font13">TEAE </span>
   <span class="font13">margin </span>
   <span class="font13">The </span>
   <span class="font13">{border-style </span>
   <span class="font12">healthy </span>
   <span class="font12">higher </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">between </span>
   <span class="font12">risk </span>
   <span class="font12">.%.% </span>
   <span class="font12">dose </span>
   <span class="font12">not </span>
   <span class="font12">TEAEs </span>
   <span class="font12">all </span>
   <span class="font12">disorders </span>
   <span class="font12">during </span>
   <span class="font12">phase </span>
   <span class="font12">safety </span>
   <span class="font11">adverse </span>
   <span class="font11">results </span>
   <span class="font11">that </span>
   <span class="font11">trials </span>
   <span class="font11">clinical </span>
   <span class="font11">data </span>
   <span class="font11">laboratory </span>
   <span class="font11">studies. </span>
   <span class="font11">â€" </span>
   <span class="font11">Clin </span>
   <span class="font11">FiH </span>
   <span class="font11">after </span>
   <span class="font11">drug </span>
   <span class="font11">from </span>
   <span class="font11">had </span>
   <span class="font11">included </span>
   <span class="font11">this </span>
   <span class="font11">â€". </span>
   <span class="font11">Table </span>
   <span class="font11">are </span>
   <span class="font11">first-in-human </span>
   <span class="font11">only </span>
   <span class="font11">step </span>
   <span class="font11">Subjects </span>
   <span class="font11">can </span>
   <span class="font11">events </span>
   <span class="font11">study </span>
   <span class="font11">system </span>
   <span class="font11">which </span>
   <span class="font11">also </span>
   <span class="font11">analysis </span>
   <span class="font11">analyzed </span>
   <span class="font11">our </span>
   <span class="font11">px; </span>
   <span class="font11">relevant </span>
   <span class="font11">see </span>
   <span class="font11">single-dose </span>
   <span class="font11">studies, </span>
   <span class="font11">subject </span>
   <span class="font11">treatment. </span>
   <span class="font11">under </span>
   <span class="font11">{font-family </span>
   <span class="font11">All </span>
   <span class="font11">Bayer </span>
   <span class="font11">Pharmacol. </span>
   <span class="font11">This </span>
   <span class="font11">[]. </span>
   <span class="font11">affected </span>
   <span class="font11">details </span>
   <span class="font11">effects </span>
   <span class="font11">font-size </span>
   <span class="font11">increases </span>
   <span class="font11">intensity </span>
   <span class="font11">limit </span>
   <span class="font11">organ </span>
   <span class="font11">reported </span>
   <span class="font11">upper </span>
   <span class="font10">Dose </span>
   <span class="font10">For </span>
   <span class="font10">double; </span>
   <span class="font10">group </span>
   <span class="font10">in-house </span>
   <span class="font10">placebo. </span>
   <span class="font10">serious </span>
   <span class="font10">treated </span>
   <span class="font10">treatment-emergent </span>
   <span class="font10">ALT </span>
   <span class="font10">Pharmacol </span>
   <span class="font10">[], </span>
   <span class="font10">administration </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">compounds </span>
   <span class="font10">considered </span>
   <span class="font10">development </span>
   <span class="font10">differences </span>
   <span class="font10">doses </span>
   <span class="font10">dosing </span>
   <span class="font10">due </span>
   <span class="font10">early </span>
   <span class="font10">increase </span>
   <span class="font10">least </span>
   <span class="font10">maximum </span>
   <span class="font10">moderate </span>
   <span class="font10">multiple </span>
   <span class="font10">other </span>
   <span class="font10">overall </span>
   <span class="font10">planned </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">steps </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">.-fold </span>
   <span class="font10">AEs </span>
   <span class="font10">GGT </span>
   <span class="font10">Overall </span>
   <span class="font10">Study </span>
   <span class="font10">about </span>
   <span class="font10">above </span>
   <span class="font10">and/or </span>
   <span class="font10">bold </span>
   <span class="font10">class </span>
   <span class="font10">confidence </span>
   <span class="font10">courier; </span>
   <span class="font10">daily </span>
   <span class="font10">drug-related), </span>
   <span class="font10">em; </span>
   <span class="font10">especially </span>
   <span class="font10">further </span>
   <span class="font10">have </span>
   <span class="font10">highest </span>
   <span class="font10">interpretation </span>
   <span class="font10">lipase, </span>
   <span class="font10">low </span>
   <span class="font10">most </span>
   <span class="font10">mostly </span>
   <span class="font10">nature </span>
   <span class="font10">normal </span>
   <span class="font10">number </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">relative </span>
   <span class="font10">risks </span>
   <span class="font10">severe </span>
   <span class="font10">show </span>
   <span class="font10">total </span>
   <span class="font10">volunteers </span>
   <span class="font10">well </span>
  </p>
 </body>
</html>
